Engineers Gate Manager’s Phathom Pharmaceuticals PHAT Stock Holding History

Engineers Gate Manager’s Portfolio PHAT Stock Details PHAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$820K	Buy	73,848 +29,590	+67%	+$374K	0.01%	1149
2025 Q4	$734K	Buy	+44,258	New	+$632K	0.01%	1184
2025 Q2	–	Sell	-26,623	Closed	-$167K	–	2452
2025 Q1	$167K	Sell	26,623 -5,877	-18%	-$35.7K	﹤0.01%	1924
2024 Q4	$264K	Buy	+32,500	New	+$402K	﹤0.01%	1763
2023 Q4	–	Sell	-12,888	Closed	-$134K	–	2178
2023 Q3	$134K	Buy	+12,888	New	+$177K	﹤0.01%	1563
2021 Q3	–	Sell	-14,310	Closed	-$484K	–	1896
2021 Q2	$484K	Buy	14,310 +5,054	+55%	+$181K	0.03%	846
2021 Q1	$348K	Buy	+9,256	New	+$387K	0.02%	1223

Other funds holding PHAT

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Engineers Gate Manager's PHAT Position: Q1 2026 in Review

Engineers Gate Manager increased its Phathom Pharmaceuticals (PHAT) stake by 67% in Q1 2026, buying an estimated $374K and bringing the position to 73,848 shares worth $820K. The position accounts for 0.01% of the portfolio, ranked #1149.

Engineers Gate Manager first reported a position in PHAT in Q1 2021 and has held it in 7 quarters since. 174 funds tracked by Wall St. Rank hold PHAT as of Q1 2026.

Engineers Gate Manager held 73,848 shares of Phathom Pharmaceuticals worth $820K as of Q1 2026.
Engineers Gate Manager bought 29,590 Phathom Pharmaceuticals shares in Q1 2026, an estimated $374K.
Phathom Pharmaceuticals made up 0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1149 holding.
Engineers Gate Manager first reported a position in Phathom Pharmaceuticals in Q1 2021 and has held it in 7 quarters since.
174 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.